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Abstract
Background: Signiﬁ  cant variation is reported in the diagnosis of HPV-associated AIN. We previously observed that band-
like positivity for p16 in 90% of contiguous cells coupled with Ki67 positivity in 50% of lesional cells is strongly 
associated with high grade AIN. This study was undertaken to determine if addition of p16 and Ki67 immunostaining would 
reduce inter- and intraobserver variability in diagnosis and grading of AIN.
Design: H&E stained slides of 60 anal biopsies were reviewed by three pathologists and consensus diagnoses were achieved: 
25 negative, 12 low (condyloma and/or AIN I) and 23 high (9 AIN II and 14 AIN III) grade lesions. The H&E stained slides 
were diagnosed independently by three additional (“participant”) pathologists. Several weeks later they re-examined these 
slides in conjunction with corresponding p16 and Ki67 immunostains.
Results: Addition of p16 and Ki67 immunostains reduced intra- and interobserver variability, improved concurrence with 
consensus diagnoses and reduced two-step differences in diagnosis. Negative and high grade AIN diagnoses showed the 
most improvement in concurrence levels.
Conclusion: Addition of p16 and Ki67 immunostains is helpful in the diagnosis and grading of AIN.
Keywords: human papilloma virus (HPV), anal intraepithelial neoplasia (AIN), condyloma, P16, Ki67, intraobserver 
variability, interobserver variability
Introduction
The incidence of anal squamous carcinoma and its precursor lesions has increased in recent years 
although the true incidence of anal intraepithelial neoplasia (AIN) is unknown (Shepherd, 2007). These 
lesions are most prevalent among HIV+ men who participate in anal receptive sex (MSM) (Daling et al. 
1982; Melbye et al. 1994; Palefsky et al. 1998; Daling et al. 2004). Prior to the human immunodeﬁ  ciency 
virus (HIV) epidemic the incidence of anal cancer in this high risk population was estimated at 36.9 
per 100,000 (Daling et al. 1982), similar to the incidence of cervical cancer prior to the establishment 
of routine cervical cytology screening programs. In HIV positive individuals the incidence of anal 
cancer has been estimated to be twice that in HIV negative individuals (Melbye et al. 1994; Goedert 
et al. 1998). The American Cancer Society projected that in 2007 about 4650 new cases of anal cancer 
would be diagnosed in the United States (up from 3400 cases in 2000 and 4010 cases in 2004) and that 
about 690 persons (up from 580 in 2004) would die of the disease during the year (American Cancer 
Society). The increased incidence of AIN is most likely due to both an increase in HPV and HIV infec-
tions and the increase in longevity attributable to antiretroviral therapy which does not appear to be 
effective against HPV infections or HPV associated neoplasia (Frisch, Biggar, Goedert, 2000; Horster 
et al. 2003; Ortholan, Francois, Gerard, 2003; Palefsky et al. 2001).
Correspondence: Ann E. Walts, M.D., Department of Pathology and Laboratory Medicine, Cedars-Sinai 
Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048. Tel: (310) 423-6626; Fax: (310) 423-0122; 
Email: walts@cshs.org8
Walts et al
Clinical Medicine: Pathology 2008:1 
As is the case for squamous lesions in the cervix, 
human papilloma viruses (HPV) have been shown 
to play an important role in the pathogenesis of the 
vast majority of these lesions (Palefsky, 2000). At 
present there exist signiﬁ  cant differences in the 
interpretation of anal biopsies that impact patient 
management (Colquhoun et al. 2003; Haber et al. 
2004; Lytwyn et al. 2005). Factors that contribute 
to intra- and interobserver variation in the interpre-
tation of anal biopsies for intraepithelial neoplasia 
(AIN) include application of subjective criteria, 
tangential sectioning, small size of biopsies, coex-
istent reactive/inﬂ  ammatory atypia and thermal 
artifact. In a recent study of anal biopsies (Walts, 
Lechago, Bose, 2006a), we found that (a) a band-
like pattern of p16 immunostaining coupled with 
Ki67 positivity in 50% of the lesional cell nuclei 
was strongly associated with high grade AIN; (b) 
absence of a p16 band of immunoreactivity, coupled 
with Ki67 positivity in 50% of lesional nuclei, 
was frequently associated with benign lesions; 
(c) most AIN I lesions stained similar to the non-
dysplastic cases; (d) band-like p16 positivity cor-
related strongly with the presence of high risk HPV 
DNA as determined by in-situ hybridization. The 
current study was undertaken to ascertain whether 
addition of p16 and Ki67 immunostains, interpreted 
in accordance with the ﬁ  ndings listed above reduces 
intra- and interobserver variability in the histologic 
diagnosis and grading of AIN.
Materials and Methods
After IRB approval, H&E stained sections of 60 
formalin ﬁ  xed anal tissue samples from 52 indi-
viduals (51 biopsies from 43 males and 9 biopsies 
from 9 females) were retrieved from the surgical 
pathology ﬁ  les of our department. Males ranged 
in age from 28 to 57 years (mean: 41 yrs; median: 
40 yrs) and females ranged in age from 19 to 72 
years (mean: 50 yrs; median: 48 yrs). Cases were 
selected to include an assortment of squamous 
lesions. No additional selection criteria were 
applied. HIV status was not known.
All slides were reviewed by two pathologists. 
After diagnostic differences had been resolved by 
discussion and/or review by a third pathologist, the 
following consensus diagnoses were achieved: 25 
negative (reactive, inﬂ  ammatory, and/or hemor-
rhoids), 12 low grade squamous intraepithelial 
lesions (condyloma and/or AIN I), and 23 high 
grade squamous intraepithelial lesions (9 AIN II 
and 14 AIN III). The slides, designated 1 to 60, 
were subsequently diagnosed independently, and 
without knowledge of prior diagnoses, by three 
additional pathologists who routinely sign out anal 
biopsies, herein designated participant pathologists. 
Diagnoses were recorded as negative, low grade 
AIN, or high grade AIN as explained above. Only 
one diagnosis was permitted per case. In sections 
showing combinations of HPV associated change 
and/or various grades of AIN, the highest grade 
lesion was recorded as the working diagnosis.
One month to six weeks later, during which time 
the three participating pathologists had been pro-
vided with the results/conclusions of our previous 
study as cited above, the cases were renumbered 
and the same 60 H&E stained slides were 
re-examined by the same three pathologists in 
conjunction with corresponding p16 and Ki67 
immunostained slides prepared as previously 
described (Walts, Lechago, Bose, 2006a). The 
diagnoses were compared statistically for intra- and 
interobserver variability.
Immunostains
Imunostaining for p16 and Ki67was performed in 
accordance with the manufacturers’ recommenda-
tions, as previously described (Walts, Lechago, 
Bose, 2006a). Nuclear and/or both nuclear and 
cytoplasmic staining in 10% of squamous cells 
was interpreted as positive for p16; cytoplasmic 
staining alone was considered nonspeciﬁ  c and inter-
preted as negative. For cases with condyloma and/or 
AIN, p16 was evaluated in the area(s) exhibiting the 
highest grade of atypia or dysplasia. The staining 
pattern for p16 was recorded as band-like when 
90% of contiguous squamous cells stained posi-
tive. For cases exhibiting a band-like staining pat-
tern, the location of the band was recorded as level 
1, 2, or 3 (conﬁ  ned to the lower third, lower two-
thirds, or full thickness, respectively of the squa-
mous epithelium). Immunostaining for Ki67 was 
exclusively nuclear and recorded as positive when 
present in 50% of lesional squamous cells in the 
area corresponding to the diagnosis and the location 
of Ki67 positive cells was recorded as level 1–3.
Statistical analysis
Results were compared statistically using weighted 
kappa analysis (StrataCorp, 2005. Stata Statistical 
Software: Release 9. College Station, TX: Stata-
Corp LP).9
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Results
Intraobserver variation in diagnosis
As shown in Table 1, each of the three participant 
pathologists changed a substantial number 
(23%–48%) of their initial 60 diagnoses after 
reviewing the p16 and Ki67 immunostains. For 
each pathologist, the changes in diagnoses com-
prised a mix of increases (8%–20%) and decreases 
(3%–33%) in severity of diagnoses. Overall, a 
decrease in severity of diagnoses was more fre-
quent. Of the total 63 diagnoses that were changed 
by the three participant pathologists, 54 (86%) were 
one-step and 9 (14%) were two-step changes in 
diagnosis. The two-step changes were equally dis-
tributed among the three participant pathologists. 
As shown in Table 2, addition of p16 and Ki67 
immunostains improved concurrence with consen-
sus diagnoses for two of the pathologists, while 
there was no net effect on the concurrence with 
consensus diagnoses for the third participant.
Interobserver variation in diagnosis
Table 3 compares the interobserver variation in 
diagnosis, while Table 4 compares the concurrence 
with consensus diagnoses before and after addition 
of p16 and Ki67 immunostains. Addition of p16 
and Ki67 immunostains eliminated all ﬁ  ve of the 
two-step differences and decreased the number of 
one-step differences in diagnosis among participat-
ing pathologists from 31 to 23 cases (26%), but 
yielded two cases for which there was no diagnos-
tic agreement among the participants. Addition of 
p16 and Ki67 immunostains increased the percent-
age of cases in which all three participant patholo-
gists agreed with each other by 18% and by which 
all agreed with the consensus diagnoses by 22% 
corresponding to an increase in overall multirater 
weighted kappa from 0.45 to 0.57. Figures 1 and 2 
illustrate two cases in which stains for p16 and 
Ki67 reconciled disparate interpretations of anal 
biopsies. The anal biopsy in Figure 1 was inter-
preted as condyloma and high grade AIN on H&E 
evaluation. Spotty p16 positivity and Ki67 
positivity in 50% of nuclei resulted in reinter-
pretation as condyloma without AIN. The anal 
biopsy in Figure 2 was interpreted as atypical 
transitional epithelium on H&E evaluation. Based 
on band-like p16 positivity and Ki67 positivity in 
50% of nuclei, the interpretation was changed to 
high grade AIN. The presence of spotty p16 stain-
ing and Ki67 staining in 50% of nuclei in the 
adjacent thickened squamous epithelium is sup-
portive of condyloma.
As shown in Table 5, addition of p16 and Ki67 
immunostains resulted in substantial improvement 
in diagnosis agreement and in kappa values for 
negative and high grade AIN cases. Kappa values 
for low grade lesions were essentially unchanged.
Discussion
AIN was ﬁ  rst described as a potentially premalig-
nant change by Fenger and Thue Nielsen (Fenger 
and Thue Nielsen, 1981) who reported histological 
changes in anal epithelium utilizing a three grade 
system (Fenger and Thue Nielsen, 1986) similar 
to that which had been developed by Richart 
(Richart, 1967) for cervical dysplasias. Acknowl-
edging the subjectivity in the histologic assessment 
and grading of cervical dysplasia and the difﬁ  cul-
ties in patient management that intra- and interob-
server variation in histologic diagnosis can create, 
Richart (Richart, 1990) subsequently proposed a 
modiﬁ  ed two-tier system for grading cervical dys-
plasia. This division of squamous dysplasias into 
low grade and high grade intraepithelial lesions 
has now been widely adopted for the cervix as well 
as the anal canal by histopathologists, cytologists 
(Solomon et al. 2002) and clinicians.
The recent increase in AIN, in concert with the 
availability of cytology and anoscopy for diagno-
sis, development of a variety of treatment modal-
ities for AIN and anticipation of vaccine(s) directed 
against HPV subtypes has renewed concerns about 
the impact of intra- and interobserver variation in 
diagnosis and grading of AIN on patient 
Table 1. Intraobserver Variation in Diagnosis: H&E vs. H&E+p16 and Ki67 (N = number of cases Total = 60 cases).
  Changed  One-step  Two-step  Severity of diagnosis
 diagnoses  change  change  Increased  Decreased
MD “A”  20 (33%)  17  3 (15%)  5  15
MD “B”  14 (23%)  12  2 (14%)  12  2
MD “C”  29 (48%)  25  4 (16%)  9  2010
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management (Carter et al. 1994; Colquhoun et al. 
2003; Lytwyn et al. 2005). In a study of H&E 
stained sections from 100 anal biopsies with ﬁ  ve 
reviewer pathologists using seven permitted diag-
noses (normal, inﬂ  ammation/HPV, AIN I, AIN II, 
AIN III, squamous carcinoma, inadequate), 
Carter et al. 1994 reported only moderate levels of 
agreement (weighted kappa scores ranging from 
0.17 to 0.60) and expressed concern that the inabil-
ity to reliably distinguish between grades of AIN 
may result in overtreatment of as many as two-
thirds of patients. Similarly, in a study where four 
Figure 1. Anal biopsy showing a) condyloma (arrowhead) and squamous epithelium equivocal for high grade AIN (arrow); b) spotty p16 
positivity in condyloma and absence of staining in epithelium equivocal for AIN; c) Ki67 positivity in 50% of nuclei.
a
bc11
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reviewer pathologists utilized three diagnoses 
(negative, low grade AIN, high grade AIN) to 
evaluate 155 anal biopsies, Lytwyn et al. 2005 
reported an overall multirater weighted kappa score 
of 0.59. There was substantial agreement in the 
diagnosis of negative vs. high grade AIN (kappa 
scores 0.63 and 0.68, respectively) but only mod-
erate agreement in the diagnosis of low grade AIN 
(kappa = 0.44). Colquohoun et al. 2003 also 
reported poor to only moderate agreement in diag-
nosis when three pathologists evaluated 190 anal 
biopsies utilizing six permitted diagnoses (normal, 
HPV change only, AIN I, AIN II, AIN III, invasive 
carcinoma). In their study, the weighted kappa 
scores achieved for HPV ranged from 0.24 to 0.53 
while the scores for dysplasia ranged from 0.38 to 
0.7. They reported agreement between the original 
pathologist and the three reviewing pathologists in 
only 32% of cases and noted that there was (a) the 
greatest level of disagreement for slides initially 
interpreted as AIN, (b) poor agreement for HPV 
changes, (c) disagreement in diagnoses at all levels 
of AIN and for the presence of invasive carcinoma. 
In contrast to the study by Carter et al. 1994 which 
only assessed interobserver variation in diagnosis, 
Colquohoun et al. 2003 also evaluated intraobserver 
variation in diagnosis for one pathologist reporting 
only moderate agreement except for invasive car-
cinoma where there was perfect intraobserver 
agreement for this individual. They suggested that 
intra- and interobserver variation in diagnosis 
could be decreased by utilizing (a) a two-tier (low 
grade, high grade) diagnosis system and (b) 
molecular biology markers rather than or in con-
junction with routine histology.
We are aware of only one other study that 
addressed the effect of immunostaining on intra- 
and interobserver variation in the diagnosis and 
grading of anal biopsies for AIN. In an abstract, 
Haber et al. 2004 reported that immunostains for 
Ki67 were helpful in distinguishing dysplastic from 
nondysplastic anal biopsies. They utilized image 
analysis (CAS 200) to assess the number of Ki67 
positive nuclei in the upper two thirds of the epi-
thelium in 102 anal biopsies. Their study involved 
three participant pathologists using four permis-
sible diagnoses (no dysplasia, mild, moderate, and 
severe dysplasia). They reported improvement in 
interobserver agreement and increase in kappa 
scores from 0.498–0.611 to 0.609–0.678. They 
concluded that immunostaining for Ki67 is helpful 
in reducing interobserver variability in grading 
AIN and state that Ki67 was “most helpful in dis-
criminating between those cases with and without 
dysplasia”.
We assessed the potential value of immunos-
tains for p16 and Ki67 interpreted in accordance 
with conclusions previously reached (Walts, 
Lechago, Bose, 2006a), to reduce intra- and 
interobserver variation in diagnosis of 60 anal 
biopsies reviewed by three pathologists. Brieﬂ  y 
p16 is a cyclin-dependent kinase inhibitor and 
regulator of the transition from G1 to the S phase 
Table 4. Interobserver Variation in diagnosis: Agree-
ment with consensus diagnosis (N = number of cases 
Total = 60 cases).
 H&E  H&E+p16 and Ki67




Multirater kappa  0.4486  0.5657




*Total diagnoses = 180 (60×3)
Table 2. Intraobserver Variation in diagnosis: Agree-
ment with consensus diagnoses (N = number of cases 
Total = 60 cases).
  Diagnosis agrees with
 consensus  diagnosis
 H&E  H&E+p16 and Ki67
MD “A”  40  49
MD “B”  51  51
MD “C”  32  41
Table 3. Interobserver Variation (N = number of cases 
Total = 60 cases).
 H&E  H&E+p16 and Ki67
All 3 participant  24  35
MDs agree 
Only 2 participant  36  23
MDs agree 
No 2 participant  0  2
MDs agree
One step difference  31  23
in diagnosis
Two step difference  5  0
in diagnosis12
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of the cell cycle that normally serves as a tumor 
suppressor. This gene product is upregulated and 
overexpressed immunohistochemically in most 
high risk HPV induced high grade cervical (Sano 
et al. 1998) and anal dysplasias and carcinomas. 
Hence, demonstration of overexpression of p16 
coupled with a marked increase in Ki67 positivity 
a
b c
Figure 2. Anal biopsy showing a) atypical transitional epithelium equivocal for high grade AIN (arrowhead); b) band-like p16 positivity in high 
grade AIN and c) Ki67 positivity in 50% of nuclei in high grade AIN.
should more closely reﬂ  ect HPV induced AIN than 
Ki67 positivity alone. Our study conﬁ  rms the 
existence of signiﬁ  cant intra- and interobserver 
variation in assessment and grading of AIN when 
based only on routine stains. Our ﬁ  ndings (illus-
trated in Figs. 1 and 2) indicate that when interpreted 
in accordance with our previously derived 13
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guidelines, immunostains for p16 and Ki67 are 
helpful in reducing variation in the diagnosis and 
grading of AIN. While addition of the immunos-
tains improved the kappa values for each diagnos-
tic category, the improvement was most signiﬁ  cant 
for the negative and high grade AIN categories. 
Based on our present ﬁ  ndings, we recommend that 
p16 and Ki67 immunostains be incorporated into 
the histopathologic evaluation of anal biopsies for 
HPV associated AIN. The beneﬁ  t is most apparent 
in diagnostically difﬁ  cult cases particularly those 
instances when the differential diagnosis includes 
high grade AIN as evidenced in our previous study 
of selected diagnostically difﬁ  cult cases of AIN 
(Walts et al. 2006b). Addition of p16 and Ki67 
immunostains in the evaluation of these cases can 
reduce false positive as well as false negative 
diagnoses of high grade AIN.
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